Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors
Clinical trial NCT05154630 · TERMINATED
Trial details
- NCT number
- NCT05154630
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2023-03-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.